A carregar...
Trastuzumab-induced cardiotoxicity: testing a clinical risk score in a real-world cardio-oncology population
BACKGROUND: Trastuzumab has improved survival for women with her2-positive breast cancer, but its use is associated with an increased risk of cardiotoxicity. With increased survivorship, the long-term effects of cancer treatment are an important consideration for clinicians and patients. We reviewed...
Na minha lista:
| Publicado no: | Curr Oncol |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Multimed Inc.
2017
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5486382/ https://ncbi.nlm.nih.gov/pubmed/28680277 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3747/co.24.3349 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|